Zyoud Sa'ed H, Shakhshir Muna, Koni Amer, Abushanab Amani S, Shahwan Moyad, Jairoun Ammar Abdulrahman, Al Subu Rand, Abu Taha Adham, Al-Jabi Samah W
Department of Clinical and Community Pharmacy, College of Medicine and Health Sciences, An-Najah National University, Nablus 44839, Palestine.
Poison Control and Drug Information Center, College of Medicine and Health Sciences, An-Najah National University, Nablus 44839, Palestine.
World J Diabetes. 2022 Sep 15;13(9):786-798. doi: 10.4239/wjd.v13.i9.786.
BACKGROUND: Insulin resistance is a risk factor for metabolic syndromes and is associated with a wide variety of metabolic illnesses, including obesity, type 2 diabetes, and cardiovascular disease. AIM: To investigate and map global insulin resistance studies. METHODS: A bibliometric methodology was applied to the literature retrieved from the Scopus database and (https://www.referencecitationanalysis.com) by using a validated search strategy. The study period was limited from 2002 to 2021. Bibliometric indicators and mapping were presented. RESULTS: A total of 26808 articles on the topic of insulin resistance were included in the Scopus database. The articles included research articles ( = 21918; 81.76%), review articles ( = 2641; 9.85%), and letters ( = 653; 2.44%). During the study period, 136 countries contributed to the research on insulin resistance. The highest number of articles was from the United States ( = 7360; 27.45%), followed by China ( = 3713; 13.85%), Japan ( = 1730, 6.45%), Italy ( = 1545; 5.54%), and the United Kingdom ( = 1484; 5.54%). The retrieved articles identified two main research themes: "inflammatory mechanisms in the regulation of insulin resistance" and "mechanisms linking obesity to insulin resistance". CONCLUSION: Our data show that insulin resistance has steadily gained interest from researchers, as evidenced by the number of citations and yearly publications. Publications have grown significantly in the last decade, while low-income countries with greater burdens continue to produce fewer publications in this field. This approach might assist researchers in choosing new research areas and recognizing research hotspots and frontiers. In the future, perhaps high-quality clinical evidence will be acquired.
背景:胰岛素抵抗是代谢综合征的一个危险因素,与多种代谢性疾病相关,包括肥胖、2型糖尿病和心血管疾病。 目的:调查并绘制全球胰岛素抵抗研究的图谱。 方法:采用文献计量学方法,通过经过验证的检索策略,对从Scopus数据库和(https://www.referencecitationanalysis.com)检索到的文献进行分析。研究时间段限定为2002年至2021年。呈现文献计量指标并绘制图谱。 结果:Scopus数据库共收录了26808篇关于胰岛素抵抗主题的文章。这些文章包括研究论文(n = 21918;81.76%)、综述文章(n = 2641;9.85%)和信函(n = 653;2.44%)。在研究期间,136个国家参与了胰岛素抵抗的研究。文章数量最多的是美国(n = 7360;27.45%),其次是中国(n = 3713;13.85%)、日本(n = 1730,6.45%)、意大利(n = 1545;5.54%)和英国(n = 1484;5.54%)。检索到的文章确定了两个主要研究主题:“胰岛素抵抗调节中的炎症机制”和“肥胖与胰岛素抵抗的关联机制”。 结论:我们的数据表明,胰岛素抵抗一直稳步吸引着研究人员的关注,这从引用次数和年度出版物数量可以看出。在过去十年中,出版物数量显著增长,而负担较重的低收入国家在该领域的出版物仍然较少。这种方法可能有助于研究人员选择新的研究领域,并识别研究热点和前沿。未来,或许将获得高质量的临床证据。
World J Diabetes. 2022-9-15
J Health Popul Nutr. 2023-4-15
J Health Popul Nutr. 2024-1-9
World J Clin Oncol. 2022-10-24
World J Gastroenterol. 2024-6-28
Ann Clin Microbiol Antimicrob. 2016-9-23
World J Gastrointest Surg. 2021-11-27
World J Gastroenterol. 2022-7-7
Front Endocrinol (Lausanne). 2024
J Diabetes Metab Disord. 2024-2-14
World J Gastrointest Oncol. 2024-5-15
J Health Popul Nutr. 2024-1-9
Eur J Med Res. 2023-11-28
World J Gastrointest Surg. 2021-11-27
Diabetes Metab Syndr. 2021
Arch Public Health. 2021-4-13